Latest

19:44
[ BOSS ZHIPIN-W (02076.HK): Chen Xu steps down as President to become CMO, Zhang Tao appointed rotating President ] On 1 September 2026, BOSS ZHIPIN-W (02076.HK) announced that Mr. Chen Xu has ceased to act as President due to the rotation arrangement, remaining an executive Director and resuming the role of Chief Marketing Officer, while Mr. Zhang Tao was appointed rotating President with a term until 31 August 2027, continuing as an executive Director and Chief Technology Officer reporting to founder, Chairman and CEO Zhao Peng.
Tag： BOSS ZHIPIN-W02076.HKBoard Changes
19:24
[ C STRATEGIC TEC (01725.HK): Unaudited August revenue of approximately RMB 52.27 million, down 70.97% year on year ] On 1 September 2026, C STRATEGIC TEC (01725.HK) reported unaudited August 2026 revenue of approximately RMB 52.27 million, down approximately 70.97% year on year (August 2025: approximately RMB 180.07 million). The Group, centered on aerospace technology, operates four segments covering the aerospace industry, precision manufacturing, new energy vessels and biotechnology; the figures are unaudited and may differ from those in periodic financial reports.
Tag： C STRATEGIC TEC01725.HKresults
19:22
[ NSING TECH (02701.HK): Plans RMB 60 million investment in Nanjing UCUN Technology at RMB 590 million pre-money valuation for 8.33% stake ] On 1 September 2026, NSING TECH (02701.HK) announced a plan to invest RMB 60 million of H-share proceeds in Nanjing UCUN Technology Inc. (UCUN) at a pre-money valuation of RMB 590 million, subscribing for new registered capital representing an 8.3333% stake after the investment, to strengthen its customized NOR Flash external storage MCU capabilities. The investment was approved unanimously by the Board, does not constitute a connected transaction, and does not constitute a major asset restructuring.
Tag： NSING TECH02701.HKacquisition
19:19
[ SERES (09927.HK): August total sales of 27,684 vehicles down 39.58% year on year, NEV sales fall 43.96% to 24,244 units ] On 1 September 2026, SERES (09927.HK) reported August 2026 total production of 26,531 vehicles, down 43.67% year on year, and total sales of 27,684 vehicles, down 39.58%, with NEV sales of 24,244 units, down 43.96% and Seres Automobile sales of 20,652 units, down 49.68%. Cumulative total sales for the first eight months reached 250,943 vehicles, down 14.17% year on year.
Tag： Seres09927.HKresults
19:06
[ CSPC PHARMA (01093.HK): ADC candidate SYS6010 receives another Breakthrough Therapy designation in China for recurrent or metastatic head and neck squamous cell carcinoma ] On 1 September 2026, CSPC PHARMA (01093.HK) announced that SYS6010, its EGFR-targeting antibody-drug conjugate, has been granted another Breakthrough Therapy designation by the NMPA for recurrent or metastatic head and neck squamous cell carcinoma in patients who failed prior immunotherapy and platinum-based chemotherapy. The product has previously received two Breakthrough Therapy designations, and a pivotal Phase III clinical trial of the product as monotherapy for the indication is underway.
Tag： CSPC PHARMA01093.HKR&D Progress
19:03
[ GWMOTOR (02333.HK): August sales of 113,396 vehicles down 1.87% year on year, NEV sales reach 40,700 units with ORA more than doubling ] On 1 September 2026, GWMOTOR (02333.HK) reported August 2026 sales of 113,396 vehicles, down 1.87% year on year, with cumulative sales of 805,358 vehicles in the first eight months, up 1.98%. August overseas sales totaled 62,517 units and NEV sales reached 40,700 units, with ORA brand sales more than doubling year on year.
Tag： GWMOTOR02333.HKresults
19:02
[ SWIRE PACIFIC A (00019.HK): Joint transaction coordinators appointed for potential accelerated exchange transaction of HKD 4.7 billion zero-coupon exchangeable bonds ] On 1 September 2026, SWIRE PACIFIC A (00019.HK) announced the appointment of J.P. Morgan Securities (Asia Pacific) Limited, Morgan Stanley & Co. International plc and The Hongkong and Shanghai Banking Corporation Limited as joint transaction coordinators for a potential accelerated exchange transaction of the HKD 4.7 billion zero-coupon exchangeable bonds due 2027 issued by its wholly-owned subsidiary Swire Pacific Finance, under which the Company would repurchase bonds and concurrently place Cathay Pacific Airways shares to independent third parties. If 90% or more of the aggregate principal amount of bonds is exchanged, repurchased and cancelled, all outstanding bonds may be redeemed at their principal amount.
Tag： SWIRE PACIFIC A00019.HKDebt Issuance
19:02
[ SUNEVISION(01686.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 1.15 billion, YoY increase of 16.96% ] NewTimeSpace News: September 01, 2026, SUNEVISION(01686.HK) released its Annual Report for the period ended June 30, 2026, Total Revenue stood at HKD 3.12 billion, increased by 6.09% YoY.
Tag： SUNEVISION01686.HKprofit growth
19:02
[ NIO-SW(09866.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 1.22 billion, loss narrowed by 89.88% YoY ] NewTimeSpace News: September 01, 2026, NIO-SW(09866.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 57.67 billion, increased by 85.77% YoY.
Tag： NIO-SW09866.HKloss narrowed
18:59
[ CONCORD HC GP (02453.HK): Controlling shareholder releases existing pledge and repledges 96,137,318 domestic shares as security for RMB 300 million loan facility ] On 1 September 2026, CONCORD HC GP (02453.HK) announced that controlling shareholder Shanghai Medstar had its existing pledge of the Company's domestic shares fully released on the same day and repledged 96,137,318 domestic shares, representing approximately 49.96% of its directly held shares, in favor of China Credit Trust Co., Ltd. as security for a loan facility of up to RMB 300 million. The aggregate pledged domestic shares represent approximately 12.27% of the total issued shares of the Company.
Tag： CONCORD HC GP02453.HKshare pledge
18:57
[ CSPC PHARMA (01093.HK): Phase I clinical trial of SYH2056 tablets for major depressive disorder officially initiated in China ] On 1 September 2026, CSPC PHARMA (01093.HK) announced that the Phase I clinical trial (SYH2056-001) of SYH2056 tablets for the treatment of major depressive disorder has been officially initiated in China. The product is a small-molecule partial 5-HT2A receptor agonist that demonstrated antidepressant efficacy in animal models with a single dose, and preclinical data indicated low risks of off-target effects, hallucinogenic potential and drug dependence. Participant recruitment and screening are underway.
Tag： CSPC PHARMA01093.HKR&D Progress
18:32
[ TST PROPERTIES(00247.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 2.72 billion, YoY increase of 16.86% ] NewTimeSpace News: September 01, 2026, TST PROPERTIES(00247.HK) released its Annual Report for the period ended June 30, 2026, Total Revenue stood at HKD 9.33 billion, increased by 13.32% YoY.
Tag： TST PROPERTIES00247.HKprofit growth
18:32
[ SINO LAND(00083.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 4.59 billion, YoY increase of 14.18% ] NewTimeSpace News: September 01, 2026, SINO LAND(00083.HK) released its Annual Report for the period ended June 30, 2026, Total Revenue stood at HKD 9.27 billion, increased by 13.32% YoY.
Tag： SINO LAND00083.HKprofit growth
18:32
[ SINO HOTELS(01221.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 97.52 million, YoY decrease of 5.64% ] NewTimeSpace News: September 01, 2026, SINO HOTELS(01221.HK) released its Annual Report for the period ended June 30, 2026, Total Revenue stood at HKD 127.48 million, increased by 3.53% YoY.
Tag： SINO HOTELS01221.HKProfit declined
17:58
[ SHEIN-W (00625.HK): Drops nearly 10% intraday on debut, market value once eroded by over HKD 20 billion ] On 1 September 2026, SHEIN-W (00625.HK) was listed on HKEX, closing at HKD 48.50 per share, down 0.12%, with a market capitalisation of approximately HKD 205 billion and an intraday maximum drop of nearly 10%; as the largest cross-border e-commerce IPO in Hong Kong in 2026, it set a final offer price of HKD 48.56 and raised gross proceeds of approximately HKD 13.596 billion (net proceeds of approximately HKD 13.214 billion), with inventory turnover of just 36 days in 2025 under its small-batch, quick-response model.
Tag： SHEIN-W00625.HKListing
17:56
[ MECH-MIND (09615.HK): Embodied intelligence "eye-brain-hand" first stock lists, closes at HKD 99.8 on debut ] On 1 September 2026, MECH-MIND (09615.HK) was listed on the Main Board of HKEX with a base offering size of USD 300 million, up to USD 345 million upon exercise of the over-allotment option, and cornerstone investment of USD 186 million; as the first "eye-brain-hand" embodied intelligence stock on the Hong Kong market, it closed at HKD 99.8 on its debut, down 1.87% from the offer price.
Tag： Mech-Mind Robotics09615.HKListing
17:48
[ GDC (08271.HK): Guangzhou court dismisses all claims of RMB 129.8 million against subsidiary ] On 1 September 2026, GDC (08271.HK) announced that its indirect wholly-owned subsidiary received a civil judgment from the Guangzhou Intermediate People's Court on 31 August 2026, under which all claims of approximately RMB 129.8 million brought by the plaintiff Pearl River Film Studio were dismissed, and both parties may appeal within 15 days of service of the judgment.
Tag： GDC08271.HKLitigation
17:44
[ CHINANEWENERGY (01156.HK): Appoints Mr. Xu Wei as Acting Chief Executive Officer ] On 1 September 2026, CHINANEWENERGY (01156.HK) announced the appointment of Xu Wei as Acting CEO for a three-year term with a monthly salary of HKD 25,000; he will focus on developing AI computing and energy storage equipment businesses to diversify revenue.
Tag： CHINANEWENERGY01156.HK
17:26
[ Shanghai-Shenzhen Stock Connect ETFs Daily Report: Grain ETFs Surge Over 6%! SSE STAR Semiconductor ETFs Plunge Over 4%, Extreme Value-Growth Divergence - 20260901 ] On September 1, 2026, grain and bank ETFs under Shanghai-Shenzhen Stock Connect surged broadly. Penghua Guozheng Food industry ETF (159698.SZ) rose 6.05%, and China Universal CSI Banks ETF (512820.SH) rose 2.20%; ChinaAMC China Science And Technology Innovation Board Semiconductor Material Equipment Theme ETF (588170.SH) fell 4.17%, with semiconductor equipment and SSE STAR growth ETFs broadly down more than 3.5%. NewTimeSpace monitoring shows an extreme rotation pattern of value defensive segments fully taking over while technology growth suffers an across-the-board slump.
Tag： Shanghai-Shenzhen Stock Connect ETFs Daily ReportPenghua Guozheng Food industry ETFChinaAMC China Science And Technology Innovation Board Semiconductor Material Equipment Theme ETF
17:23
[ SSY GROUP (02005.HK): Trustee purchases 1,000,000 shares under restricted share award scheme for approximately HKD 2.73 million ] NewTimeSpace News: On 1 September 2026, SSY GROUP (02005.HK) announced that the trustee of its restricted share award scheme purchased 1,000,000 shares on the open market at an average consideration of approximately HKD 2.7306 per share, totalling approximately HKD 2,730,600 and representing approximately 0.034% of the issued shares; the trustee's share balance stood at 14,180,000 shares, approximately 0.480%, immediately after the purchase.
Tag： SSY Group02005.HKShare Award Scheme
Previous1..9293 949596..576     576 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments